Last Funding Type: Series C
Funding Status: IPO
Headquarters: London, England, United Kingdom
Founded Date: 2015
Investor Type: Company
Investment Stage: N/A
Total Funding: $310.5M
Technology: Others
Employee Number: 51-100
Number Of Exists: Series C
Estimated Revenue: $1M to $10M
Investors Number: 24
Industry: Gene Therapy